Revance Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
Revance Therapeutics, Inc. has filed 947 SEC EDGAR filings since 23 Dec 2009

SEC filing history

Showing 151-175 of 946 matching filings.

Per page
25
Current page
7
4

FORM 4

Filing date
03 Jan 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
18 Dec 2023
Reporting date
15 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-275548

S-3ASR

Filing date
14 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88023

SC 13D/A

Filing date
24 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Sep 2023
Reporting date
05 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36297

144 filing

Filing date
06 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36297

144 filing

Filing date
05 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-88023

SC 13D

Filing date
01 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Aug 2023
Reporting date
11 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Aug 2023
Reporting date
11 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Aug 2023
Reporting date
11 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
15 Aug 2023
Reporting date
11 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Aug 2023
Reporting date
03 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36297

144 filing

Filing date
03 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jul 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jul 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
05 Jul 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .